首页> 中文期刊> 《药学学报:英文版》 >Commentary:Can FXR serve as a potential target for COVID-19 prevention?

Commentary:Can FXR serve as a potential target for COVID-19 prevention?

         

摘要

A research article has been accepted by Nature very recently entitled:FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.This is a multiple-author study by 80 scientists from 40 different research units in UK,Germany,Greece,USA,Austria,Sweden,and Norway,with Teresa Brevini as the 1st author and one of the senior authors^(1).The pre-print of this study was posted online back to June 7,2021(bioRxiv).

著录项

  • 来源
    《药学学报:英文版》 |2023年第4期|1786-1788|共3页
  • 作者单位

    Division of Nutrition;

    School of Public Health;

    Sun Yat-sen University;

    Guangzhou 510080;

    China;

    Banting and Best Diabetes Centre;

    Faculty of Medicine;

    University of Toronto;

    Toronto;

    ON M5G 2C4;

    Canada;

    Dept.of Physiology;

    University of Toronto;

    Toronto;

    ON M5G 1X8;

    Canada;

    Division of Advanced Diagnostics;

    Toronto General Hospital Research Institute;

    University Health Network;

    Toronto;

    ON M5G 2C4;

    Canada;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 药物化学;
  • 关键词

    COVID-19; ACE2; FXR; Bile acid;

相似文献

  • 中文文献
  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号